S. Schulz

发表

No association of paraoxonase-1 Q192R genotypes with platelet response to clopidogrel and risk of stent thrombosis after coronary stenting.

A. Kastrati, J. Mehilli, A. Schömig, 2011, European heart journal.

Abciximab and heparin versus bivalirudin for non-ST-elevation myocardial infarction.

Jörg Hausleiter, Karl-Ludwig Laugwitz, Ilka Ott, 2011, The New England journal of medicine.

Serum potassium levels on admission and infarct size in patients with acute myocardial infarction.

A. Kastrati, J. Mehilli, A. Schömig, 2009, Clinica chimica acta; international journal of clinical chemistry.

Will we ever know the optimal duration of dual antiplatelet therapy after drug-eluting stent implantation?

A. Kastrati, R. Byrne, S. Schulz, 2011, JACC. Cardiovascular interventions.

Platelet aggregation and its association with stent thrombosis and bleeding in clopidogrel-treated patients: initial evidence of a therapeutic window.

S. Steinhubl, A. Kastrati, A. Schömig, 2010, Journal of the American College of Cardiology.

Comparative efficacy of 2 zotarolimus-eluting stent generations: resolute versus endeavor stents in patients with coronary artery disease.

A. Kastrati, J. Mehilli, A. Schömig, 2013, American heart journal.

Antiplatelet efficacy of prasugrel in patients with high on-clopidogrel treatment platelet reactivity and a history of coronary stenting

A. Kastrati, A. Schömig, D. Sibbing, 2013, Thrombosis and Haemostasis.

The impact of smoking on the antiplatelet action of clopidogrel in non‐ST‐elevation myocardial infarction patients: results from the ISAR‐REACT 4 platelet substudy

A. Kastrati, J. Mehilli, A. Schömig, 2012, Journal of thrombosis and haemostasis : JTH.

Predictors of antiplatelet response to prasugrel during maintenance treatment

M. Hadamitzky, H. Schunkert, A. Kastrati, 2015, Platelets.

Bivalirudin versus unfractionated heparin during percutaneous coronary intervention.

A. Kastrati, J. Mehilli, J. Dirschinger, 2008, The New England journal of medicine.

Abciximab in Patients With Acute ST-Segment–Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention After Clopidogrel Loading: A Randomized Double-Blind Trial

S. Nekolla, M. Schwaiger, A. Kastrati, 2009, Circulation.

Bleeding after percutaneous coronary intervention with Bivalirudin or unfractionated Heparin and one-year mortality.

A. Kastrati, J. Mehilli, F. Neumann, 2010, The American journal of cardiology.

Drug-eluting versus bare-metal stents in saphenous vein graft lesions (ISAR-CABG): a randomised controlled superiority trial

A. Kastrati, J. Mehilli, F. Neumann, 2011, The Lancet.

Prasugrel plus bivalirudin vs. clopidogrel plus heparin in patients with ST-segment elevation myocardial infarction.

H. Schunkert, A. Kastrati, J. Mehilli, 2014, European heart journal.

Comparison of Prasugrel and Bivalirudin vs Clopidogrel and Heparin in Patients With ST‐Segment Elevation Myocardial Infarction: Design and Rationale of the Bavarian Reperfusion Alternatives Evaluation (BRAVE) 4 Trial

H. Schunkert, A. Kastrati, J. Mehilli, 2014, Clinical cardiology.

Randomized Comparison of Ticagrelor versus Prasugrel in Patients with Acute Coronary Syndrome and Planned Invasive Strategy—Design and Rationale of the Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment (ISAR-REACT) 5 Trial

H. Schunkert, A. Kastrati, F. Neumann, 2014, Journal of Cardiovascular Translational Research.

Bivalirudin Versus Heparin Plus a Glycoprotein IIb/IIIa Inhibitor in Patients With Non–ST-Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention After Clopidogrel Pretreatment: Pooled Analysis from the ACUITY and ISAR-REACT 4 Trials

G. Stone, A. Kastrati, J. Mehilli, 2012, Circulation. Cardiovascular interventions.

Antiplatelet effects of clopidogrel and bleeding in patients undergoing coronary stent placement

A. Kastrati, J. Mehilli, A. Schömig, 2010, Journal of thrombosis and haemostasis : JTH.

Troponin level and efficacy of abciximab in patients with acute coronary syndromes undergoing early intervention after clopidogrel pretreatment

A. Kastrati, J. Mehilli, J. Dirschinger, 2008, Clinical Research in Cardiology.

Biodegradable polymer versus permanent polymer drug-eluting stents and everolimus- versus sirolimus-eluting stents in patients with coronary artery disease: 3-year outcomes from a randomized clinical trial.

M. Hadamitzky, A. Wieczorek, A. Kastrati, 2011, Journal of the American College of Cardiology.

Oral anticoagulation with coumarin derivatives and antiplatelet effects of clopidogrel.

A. Kastrati, J. Mehilli, A. Schömig, 2010, European heart journal.

Aspirin and clopidogrel with or without phenprocoumon after drug eluting coronary stent placement in patients on chronic oral anticoagulation

A. Kastrati, J. Mehilli, A. Schömig, 2008, Journal of internal medicine.

Glycoprotein IIb/IIIa Receptor Inhibition with Abciximab during Percutaneous Coronary Interventions Increases the Risk of Bleeding in Patients with Impaired Renal Function

A. Kastrati, J. Mehilli, A. Schömig, 2008, Cardiology.

Rationale and design of a randomised clinical trial comparing vascular closure device and manual compression to achieve haemostasis after diagnostic coronary angiography: the Instrumental Sealing of ARterial puncture site - CLOSURE device versus manual compression (ISAR-CLOSURE) trial.

C. Hengstenberg, H. Schunkert, A. Kastrati, 2014, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Platelet function and coagulation in patients with STEMI and peri-interventional clopidogrel plus heparin vs. prasugrel plus bivalirudin therapy (BRAVE 4 substudy).

A. Kastrati, J. Mehilli, J. Hausleiter, 2016, Thrombosis research.

Prognostic significance of epicardial blood flow before and after percutaneous coronary intervention in patients with acute coronary syndromes.

A. Kastrati, J. Mehilli, M. Seyfarth, 2008, Journal of the American College of Cardiology.

One-year clinical outcomes with abciximab in acute myocardial infarction: results of the BRAVE-3 randomized trial

A. Kastrati, J. Mehilli, J. Dirschinger, 2010, Clinical Research in Cardiology.

Zotarolimus- versus everolimus-eluting stents for unprotected left main coronary artery disease.

A. Kastrati, J. Mehilli, M. Seyfarth, 2013, Journal of the American College of Cardiology.

Influence of abciximab on evolution of left ventricular function in patients with non-ST-segment elevation acute coronary syndromes undergoing PCI after clopidogrel pretreatment: lessons from the ISAR-REACT 2 trial

A. Kastrati, J. Mehilli, F. Dotzer, 2011, Clinical Research in Cardiology.

No Association of ABCB1 C3435T Genotype With Clopidogrel Response or Risk of Stent Thrombosis in Patients Undergoing Coronary Stenting

A. Kastrati, J. Mehilli, A. Schömig, 2012, Circulation. Cardiovascular interventions.

SUPPLEMENTAL MATERIAL No Association of ABCB 1 C 3435 T Genotype with Clopidogrel Response or Risk of Stent Thrombosis in Patients Undergoing Coronary Stenting

A. Kastrati, J. Mehilli, A. Schömig, 2012 .

Statin effect on thrombin inhibitor effectiveness during percutaneous coronary intervention: a post-hoc analysis from the ISAR-REACT 3 trial

A. Kastrati, J. Mehilli, J. Dirschinger, 2011, Clinical Research in Cardiology.

High frequency of CYP2C19*2 carriers in PCI-treated patients switched over from clopidogrel to prasugrel based on platelet function monitoring

A. Kastrati, A. Schömig, D. Sibbing, 2013, Platelets.

High-sensitivity troponin T level and angiographic severity of coronary artery disease.

A. Kastrati, J. Mehilli, A. Schömig, 2011, The American journal of cardiology.

Prognostic value of minimal blood flow restoration in patients with acute myocardial infarction after reperfusion therapy

A. Kastrati, J. Mehilli, M. Seyfarth, 2009, Clinical Research in Cardiology.

Platelet response to clopidogrel and restenosis in patients treated predominantly with drug-eluting stents.

A. Kastrati, J. Mehilli, A. Schömig, 2010, American heart journal.

Drug-eluting stents in acute myocardial infarction: updated meta-analysis of randomized trials

E. D. Lorenzo, A. Kastrati, J. Mehilli, 2010, Clinical Research in Cardiology.

Risk of drug-eluting stent thrombosis in patients receiving proton pump inhibitors

A. Kastrati, J. Mehilli, A. Schömig, 2010, Thrombosis and Haemostasis.

Erythropoietin in Patients With Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A Randomized, Double-Blind Trial

M. Hadamitzky, M. Schwaiger, A. Kastrati, 2010, Circulation. Cardiovascular interventions.

A comparative cohort study on personalised antiplatelet therapy in PCI-treated patients with high on-clopidogrel platelet reactivity

H. Schunkert, A. Kastrati, J. Hausleiter, 2014, Thrombosis and Haemostasis.

Prognostic value of a high on-clopidogrel treatment platelet reactivity in bivalirudin versus abciximab treated non-ST-segment elevation myocardial infarction patients. ISAR-REACT 4 (Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment-4) platelet substudy.

Munich, A. Kastrati, J. Mehilli, 2012, Journal of the American College of Cardiology.

Long-term risk of adverse outcomes and new malignancies in patients treated with oral sirolimus for prevention of restenosis.

A. Kastrati, J. Mehilli, J. Hausleiter, 2009, JACC. Cardiovascular interventions.

Total leucocyte count, but not C-reactive protein, predicts 1-year mortality in patients with acute coronary syndromes treated with percutaneous coronary intervention.

A. Kastrati, J. Mehilli, A. Schömig, 2009, Clinical science.

Sirolimus-eluting versus paclitaxel-eluting stents in diabetic and non-diabetic patients within sirolimus-eluting stent restenosis: results from the ISAR-DESIRE 2 trial.

M. Joner, A. Kastrati, S. Kufner, 2014, Cardiovascular revascularization medicine : including molecular interventions.

Does Size Matter?: In Search of a Physiological Definition of Myocardial Atrophy

H. Schunkert, A. Kastrati, D. Sibbing, 2017 .

Validation of the Bleeding Academic Research Consortium Definition of Bleeding in Patients With Coronary Artery Disease Undergoing Percutaneous Coronary Intervention

M. Hadamitzky, A. Kastrati, J. Mehilli, 2012, Circulation.

A. Kastrati, J. Mehilli, F. Neumann, 2013, American heart journal.

Response to Letter Regarding Article, “Validation of the Bleeding Academic Research Consortium Definition of Bleeding in Patients With Coronary Artery Disease Undergoing Percutaneous Coronary Intervention”

M. Hadamitzky, A. Kastrati, J. Mehilli, 2012 .

TCT-821 Stem Cell Mobilization by Granulocyte-Colony Stimulating Factor in Patients With Acute Myocardial Infarction: Five-year results of the REVIVAL-2 trial

A. Kastrati, I. Ott, R. Byrne, 2013 .

Stem cell mobilization by granulocyte-colony Stimulating Factor in patients with acute myocardial infarction: five-year results of the REVIVAL-2 trial

M. Joner, A. Kastrati, I. Ott, 2013 .

Acute coronary syndromes Prasugrel plus bivalirudin vs . clopidogrel plus heparin in patients with ST-segment elevation myocardial infarction

H. Schunkert, A. Kastrati, J. Mehilli, 2022 .

A. Kastrati, J. Mehilli, A. Schömig, 2012, Journal of the American College of Cardiology.

Collagen plug vascular closure devices and reduced risk of bleeding with bivalirudin versus heparin plus abciximab in patients undergoing percutaneous coronary intervention for non st-segment elevation myocardial infarction.

A. Kastrati, J. Mehilli, F. Neumann, 2013, Journal of interventional cardiology.

Second‐versus first‐generation “Limus”‐eluting stents in diabetic patients with coronary artery disease: A randomized comparison in setting of ISAR‐TEST‐4 trial

A. Kastrati, J. Mehilli, J. Pache, 2013, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Prognostic value of uric acid in patients with acute coronary syndromes.

M. Hadamitzky, A. Kastrati, J. Mehilli, 2012, The American journal of cardiology.

Prognostic value of kidney function in patients with ST-elevation and non-ST-elevation acute myocardial infarction treated with percutaneous coronary intervention.

A. Kastrati, J. Mehilli, M. Seyfarth, 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Risk of stent thrombosis among bare-metal stents, first-generation drug-eluting stents, and second-generation drug-eluting stents: results from a registry of 18,334 patients.

Michael Joner, Karl-Ludwig Laugwitz, Ilka Ott, 2013, JACC. Cardiovascular interventions.

Paclitaxel- versus sirolimus-eluting stents for unprotected left main coronary artery disease.

A. Kastrati, J. Mehilli, J. Dirschinger, 2009, Journal of the American College of Cardiology.

Randomized trial of paclitaxel- versus sirolimus-eluting stents for treatment of coronary restenosis in sirolimus-eluting stents: the ISAR-DESIRE 2 (Intracoronary Stenting and Angiographic Results: Drug Eluting Stents for In-Stent Restenosis 2) study.

A. Kastrati, J. Mehilli, A. Schömig, 2010, Journal of the American College of Cardiology.

Erythropoietin-induced progenitor cell mobilisation in patients with acute ST-segment-elevation myocardial infarction and restenosis

A. Kastrati, J. Mehilli, A. Schömig, 2012, Thrombosis and Haemostasis.

Randomized trial of three rapamycin-eluting stents with different coating strategies for the reduction of coronary restenosis.

A. Wieczorek, A. Kastrati, J. Mehilli, 2008, European heart journal.

ISAR-REACT 3A: a study of reduced dose of unfractionated heparin in biomarker negative patients undergoing percutaneous coronary intervention.

A. Kastrati, J. Mehilli, F. Neumann, 2010, European heart journal.

ISAR-REACT 3 A : a study of reduced dose of unfractionated heparin in biomarker negative patients undergoing percutaneous coronary intervention

A. Kastrati, J. Mehilli, F. Neumann, 2022 .

Stent thrombosis after drug-eluting stent implantation: incidence, timing, and relation to discontinuation of clopidogrel therapy over a 4-year period.

A. Kastrati, J. Mehilli, A. Schömig, 2009, European heart journal.

Profile of bleeding and ischaemic complications with bivalirudin and unfractionated heparin after percutaneous coronary intervention.

A. Kastrati, J. Mehilli, F. Neumann, 2008, European heart journal.

Bivalirudin vs. unfractionated heparin during percutaneous coronary interventions in patients with stable and unstable angina pectoris: 1-year results of the ISAR-REACT 3 trial.

A. Kastrati, J. Mehilli, F. Neumann, 2010, European heart journal.

Randomised, double-blind trial on the value of tapered discontinuation of clopidogrel maintenance therapy after drug-eluting stent implantation

H. Schunkert, A. Kastrati, J. Mehilli, 2014, Thrombosis and Haemostasis.

A double-blind, randomized study on prevention and existence of a rebound phenomenon of platelets after cessation of clopidogrel treatment.

A. Kastrati, J. Mehilli, M. Seyfarth, 2010, Journal of the American College of Cardiology.

Characterization of patients with bleeding complications who are at increased risk of death after percutaneous coronary intervention

A. Kastrati, J. Mehilli, F. Neumann, 2010, Heart and Vessels.

Incidence and predictors of coronary stent thrombosis: evidence from an international collaborative meta-analysis including 30 studies, 221,066 patients, and 4276 thromboses.

G. Stone, A. Kirtane, F. Gaita, 2013, International journal of cardiology.

ISAR--a story of trials with impact on practice.

A. Kastrati, J. Mehilli, A. Schömig, 2010, Circulation journal : official journal of the Japanese Circulation Society.

Rationale and design of a randomized, double-blind, placebo-controlled trial of 6 versus 12 months clopidogrel therapy after implantation of a drug-eluting stent: The Intracoronary Stenting and Antithrombotic Regimen: Safety And EFficacy of 6 Months Dual Antiplatelet Therapy After Drug-Eluting Stent

A. Kastrati, J. Mehilli, F. Neumann, 2009, American heart journal.

Relationship between platelet count and 30-day clinical outcomes after percutaneous coronary interventions

A. Kastrati, J. Mehilli, A. Schömig, 2007, Thrombosis and Haemostasis.

Patterns of Presentation and Outcomes of Patients with Acute Coronary Syndromes

A. Kastrati, J. Mehilli, M. Seyfarth, 2009, Cardiology.

Rationale and design of The Intracoronary Stenting and Antithrombotic Regimen-Testing of a six-week versus a six-month clopidogrel treatment Regimen In Patients with concomitant aspirin and oraL anticoagulant therapy following drug-Eluting stenting (ISAR-TRIPLE) study.

A. Kastrati, J. Mehilli, D. Sibbing, 2014, American heart journal.

One-year outcomes with abciximab and unfractionated heparin versus bivalirudin during percutaneous coronary interventions in patients with non-ST-segment elevation myocardial infarction: updated results from the ISAR-REACT 4 trial.

A. Kastrati, J. Mehilli, F. Neumann, 2013, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Effects of G-CSF on systemic inflammation, coagulation and platelet activation in patients with acute myocardial infarction.

A. Kastrati, A. Schömig, I. Ott, 2011, Thrombosis research.

Peak cardiac troponin-T level, scintigraphic myocardial infarct size and one-year prognosis in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction.

A. Kastrati, J. Mehilli, A. Schömig, 2010, The American journal of cardiology.

The impact of therapeutic hypothermia on on-treatment platelet reactivity and clinical outcome in cardiogenic shock patients undergoing primary PCI for acute myocardial infarction: Results from the ISAR-SHOCK registry.

M. Hadamitzky, H. Schunkert, A. Kastrati, 2015, Thrombosis research.

Weight of the bleeding impact on early and late mortality after percutaneous coronary intervention

A. Kastrati, G. Ndrepepa, S. Cassese, 2014, Journal of Thrombosis and Thrombolysis.

Bleeding after percutaneous coronary intervention in women and men matched for age, body mass index, and type of antithrombotic therapy.

H. Schunkert, A. Kastrati, F. Neumann, 2013, American heart journal.

Prognostic Value of Access and Non–Access Sites Bleeding After Percutaneous Coronary Intervention

A. Kastrati, F. Neumann, G. Ndrepepa, 2013, Circulation. Cardiovascular interventions.

2-year clinical and angiographic outcomes from a randomized trial of polymer-free dual drug-eluting stents versus polymer-based Cypher and Endeavor [corrected] drug-eluting stents.

A. Kastrati, J. Mehilli, M. Seyfarth, 2010, Journal of the American College of Cardiology.

A polymer-free dual drug-eluting stent in patients with coronary artery disease: a randomized trial vs. polymer-based drug-eluting stents.

A. Kastrati, J. Mehilli, M. Seyfarth, 2008, European heart journal.

Incidence and impact on prognosis of bleeding during percutaneous coronary interventions in patients with chronic kidney disease

H. Schunkert, A. Kastrati, F. Neumann, 2013, Clinical Research in Cardiology.

Impact of body mass index on clinical outcome in patients with acute coronary syndromes treated with percutaneous coronary intervention

A. Kastrati, J. Mehilli, M. Seyfarth, 2010, Heart and Vessels.

Individualization of dual antiplatelet therapy duration after drug-eluting stent implantation: paradigm and reality.

A. Kastrati, S. Schulz, 2013, European heart journal.

Randomized, non-inferiority trial of three limus agent-eluting stents with different polymer coatings: the Intracoronary Stenting and Angiographic Results: Test Efficacy of 3 Limus-Eluting Stents (ISAR-TEST-4) Trial.

A. Kastrati, J. Mehilli, M. Seyfarth, 2009, European heart journal.

Paclitaxel-eluting balloons, paclitaxel-eluting stents, and balloon angioplasty in patients with restenosis after implantation of a drug-eluting stent (ISAR-DESIRE 3): a randomised, open-label trial

A. Kastrati, J. Mehilli, F. Neumann, 2013, The Lancet.

Choice of Contrast Medium in Patients With Impaired Renal Function Undergoing Percutaneous Coronary Intervention

A. Kastrati, J. Mehilli, A. Schömig, 2009, Circulation. Cardiovascular interventions.

Coronary Artery Disease Paclitaxel- Versus Sirolimus-Eluting Stents for Unprotected Left Main

A. Kastrati, J. Dirschinger, M. Seyfarth, 2009 .

Impact of coronary anatomy and stenting technique on long-term outcome after drug-eluting stent implantation for unprotected left main coronary artery disease.

A. Kastrati, J. Mehilli, M. Seyfarth, 2014, JACC. Cardiovascular interventions.

Ten‐Year Clinical Outcomes of Biodegradable Versus Durable Polymer New‐Generation Drug‐Eluting Stent in Patients With Coronary Artery Disease With and Without Diabetes Mellitus

H. Schunkert, M. Joner, A. Kastrati, 2021, Journal of the American Heart Association.

Polymer-free sirolimus- and probucol-eluting versus new generation zotarolimus-eluting stents in coronary artery disease: the Intracoronary Stenting and Angiographic Results: Test Efficacy of Sirolimus- and Probucol-Eluting versus Zotarolimus-eluting Stents (ISAR-TEST 5) trial.

A. Kastrati, J. Mehilli, J. Pache, 2011, Circulation.

Incidence and prognostic value of bleeding after percutaneous coronary intervention in patients older than 75 years of age

A. Kastrati, F. Neumann, G. Ndrepepa, 2014, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Aspirin treatment and outcomes after percutaneous coronary intervention: results of the ISAR-ASPI registry.

H. Schunkert, A. Kastrati, D. Sibbing, 2014, Journal of the American College of Cardiology.

Prognostic value of bleeding after percutaneous coronary intervention in patients with diabetes.

A. Kastrati, F. Neumann, J. Pache, 2014, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Five-year outcomes from a trial of three limus-eluting stents with different polymer coatings in patients with coronary artery disease: final results from the ISAR-TEST 4 randomised trial.

H. Schunkert, A. Kastrati, S. Kufner, 2016, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Impact of inhospital stent thrombosis and cerebrovascular accidents on long-term prognosis after percutaneous coronary intervention.

H. Schunkert, A. Kastrati, G. Ndrepepa, 2014, American heart journal.

Prognostic value of sensitive troponin T in patients with stable and unstable angina and undetectable conventional troponin.

Jörg Hausleiter, Karl-Ludwig Laugwitz, Ilka Ott, 2011, American heart journal.

Impact of bivalirudin on post-procedural epicardial blood flow, risk of stent thrombosis and mortality after percutaneous coronary intervention.

H. Schunkert, A. Kastrati, G. Ndrepepa, 2016, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Correlates of poor outcome among patients with bleeding after coronary interventions

A. Kastrati, G. Ndrepepa, K. Laugwitz, 2014, Coronary artery disease.

A patient with angina at night: core curriculum chapters 3 (non-invasive imaging) and 9 (chronic ischaemic heart disease)

F. Eberli, A. Wieczorek, A. Kastrati, 2012 .

Prasugrel vs clopidogrel in cardiogenic shock patients undergoing primary PCI for acute myocardial infarction

M. Hadamitzky, J. Hausleiter, H. Schunkert, 2014, Thrombosis and Haemostasis.

Five‐year clinical outcomes of sirolimus‐eluting versus paclitaxel‐eluting stents in high‐risk patients

Karl-Ludwig Laugwitz, Adnan Kastrati, Albert Schömig, 2011, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[Treatment of Paclitaxel-eluting stent restenosis with sirolimus-eluting stent implantation: angiographic and clinical outcomes].

A. Kastrati, J. Mehilli, J. Pache, 2008, Revista espanola de cardiologia.

Randomised trial of three rapamycin-eluting stents with different coating strategies for the reduction of coronary restenosis: 2-year follow-up results

J. Mehilli, S. Kufner, K. Laugwitz, 2009, Heart.

CORONARY ARTERY DISEASE Original Studies Second-Versus First-Generation ‘‘Limus’’-Eluting Stents in Diabetic Patients with Coronary Artery Disease: A Randomized Comparison in Setting of ISAR-TEST-4 Trial

A. Kastrati, J. Mehilli, J. Pache, 2013 .

Reply: Aspirin Treatment and Outcomes After Percutaneous Coronary Intervention: Results of the ISAR-ASPI Registry.

H. Schunkert, A. Kastrati, D. Sibbing, 2015, Journal of the American College of Cardiology.

'Selective' reel syndrome?

S. Schulz, C. Kolb, H. Vražić, 2011, Europace.